dc.contributor.author | Engseth, Tina Pettersen | |
dc.contributor.author | Andersson, Erik P | |
dc.contributor.author | Solli, Guro Strøm | |
dc.contributor.author | Morseth, Bente | |
dc.contributor.author | Thomassen, Tor Oskar | |
dc.contributor.author | Noordhof, Dionne | |
dc.contributor.author | Sandbakk, Øyvind | |
dc.contributor.author | Welde, Boye | |
dc.date.accessioned | 2022-08-17T11:39:45Z | |
dc.date.available | 2022-08-17T11:39:45Z | |
dc.date.issued | 2022-04-14 | |
dc.description.abstract | Purpose: To investigate the prevalence of hormonal contraceptive (HC) use by female cross-country (XC) skiers and biathletes competing at a national and/or international level, their reasons for HC use, and to compare negative symptoms related to the HC-/menstrual cycle in HC users and non-HC users. Additionally, to characterize the self-perceived influence of HC use on training and performance.<p>
<p>Methods: A total of 113 Norwegian competitive XC skiers and biathletes completed an online questionnaire including both closed and open-ended questions. The questions were designed to assess the type of HC, reasons for use, self-reported negative symptoms related to HC-/menstrual cycle, as well as athletes' experiences regarding how HC use affects training and performance.<p>
<p>Results: In total, 68% of all the athletes used HC, with 64 and 36% of them using a progestin-only and combined type HC, respectively. Non-contraceptive reasons for HC use were reported by 51% of the progestin-only HC users vs. 75% of the combined HC users (P = 0.039), with reduction of negative menstrual-related symptoms as the most common reason. Of the athletes reporting regular withdrawal bleedings in connection to HC use, 80% of the progestin-only and 86% of combined HC users experienced negative menstrual-related symptoms, which was comparable to the non-HC group (86%). The majority (81%) of HC users experienced solely positive, or no effect, of HC use on training and performance, with no differences between progestin-only and combined HC users (P = 0.942).<p>
<p>Conclusions: In total, 68% of the XC skiers and biathletes used HC, with the highest proportion (64%) using a progestin-only HC. Many athletes used HC to manipulate their menstrual cycle due to perceived negative menstrual-related symptoms that interfered with their training sessions and/or competitions. | en_US |
dc.identifier.citation | Engseth T, Andersson E, Solli GS, Morseth B, Thomassen TO, Noordhof D. A., Sandbakk Ø, Welde B. Prevalence and Self-Perceived Experiences With the Use of Hormonal Contraceptives Among Competitive Female Cross-Country Skiers and Biathletes in Norway: The FENDURA Project. Frontiers in Sports and Active Living. 2022;4 | en_US |
dc.identifier.cristinID | FRIDAID 2017878 | |
dc.identifier.doi | 10.3389/fspor.2022.873222 | |
dc.identifier.issn | 2624-9367 | |
dc.identifier.uri | https://hdl.handle.net/10037/26238 | |
dc.language.iso | eng | en_US |
dc.publisher | Frontiers Media | en_US |
dc.relation.ispartof | Engseth, T.P. (2024). The perception of the menstrual cycle, cycle-related symptoms, and hormonal contraception in female endurance athletes: The FENDURA project. (Doctoral thesis). <a href=https://hdl.handle.net/10037/33779>https://hdl.handle.net/10037/33779</a> | |
dc.relation.journal | Frontiers in Sports and Active Living | |
dc.relation.projectID | Tromsø forskningsstiftelse: 19_FENDURA_BW | en_US |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2022 The Author(s) | en_US |
dc.title | Prevalence and Self-Perceived Experiences With the Use of Hormonal Contraceptives Among Competitive Female Cross-Country Skiers and Biathletes in Norway: The FENDURA Project | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |